BioCentury | Apr 7, 2021
Product Development
As Scholar Rock readies for SMA Phase III, investors shed shares amid varied durability data
...Senior Editor Scholar Rock is moving apitegromab (SRK-015) into Phase III this year, but the myostatin...
...October, Scholar Rock’s share price more than doubled.TARGETSMSTN (GDF8) – Myostatin Lauren Martz Apitegromab (SRK-015) Scholar Rock Holding Corp. Myostatin (MSTN) (GDF8) SMA...
...October, Scholar Rock’s share price more than doubled.TARGETSMSTN (GDF8) – Myostatin Lauren Martz Apitegromab (SRK-015) Scholar Rock Holding Corp. Myostatin (MSTN) (GDF8) SMA...